Hemp THC Rules: With a federal crackdown on intoxicating hemp products set for Dec. 11, Sens. Tim Sheehy and Amy Klobuchar have introduced a bill to regulate products rather than drive them off shelves. Hemp processors are backing the push, while a Wisconsin co-op says the restrictions will force its La Crosse store to close. Industry Strain: Michigan has lost 94% of its registered hemp growers since 2020, amid higher licensing fees and market uncertainty. Medical Cannabis: Companies are asking a court to block DEA guidance they say could disrupt state-regulated medical markets. Hemp Research: Texas A&M researchers have developed hemp with no detectable cannabinoids, a trait that could reduce crop-loss risk and revive fiber and grain production. Market Milestone: Missouri’s legal cannabis sales have generated nearly $1 billion in tax revenue for state and local governments.
AGP Executive Report
Your go-to archive of top headlines, summarized for quick and easy reading.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Hemp Rules: A federal crackdown set for Dec. 11 would cap THC at 0.4 milligrams per container, threatening most intoxicating hemp products and putting retailers on notice. The bipartisan Hemp Guardrails Act offers a path to regulate products instead, but Congress has yet to resolve the dispute. Retail Expansion: Massachusetts regulators cleared dispensaries to pursue drive-through sales under existing rules, with strict ID checks still required. State Policy: Texas lawmakers are weighing cannabis bills after the midterms, while Wisconsin Democrats say they want to legalize marijuana as the federal hemp change threatens a major local industry.
Federal Hemp Rules: A Dec. 11 federal limit of 0.4 milligrams of THC per container threatens many hemp-derived drinks and edibles, forcing businesses in Wisconsin and elsewhere to prepare to pull products from shelves. Bipartisan senators Tim Sheehy and Amy Klobuchar have proposed a regulatory framework to avert the crackdown, but two Republican senators say they’ll oppose any funding bill that keeps the products legal. State Policy: Wisconsin’s incoming Democratic leaders are backing cannabis legalization, offering hemp businesses a potential path forward as federal restrictions loom. In North Carolina, an advisory council recommends regulating intoxicating THC products, with proposals including age limits, testing and state-controlled sales. Global Industry: Ghana’s cannabis industry used a Japan hemp expo to discuss investment in cultivation, processing and CBD, while emphasizing research, product quality and regulatory compliance.
Hemp THC Rules: A federal 0.4-milligram total-THC-per-container limit due Dec. 11 is rattling hemp businesses, with North Carolina retailers bracing for lost sales and Wisconsin operators seeking a state-level path forward. Minnesota officials say THC drinks and edibles can remain legal under state law, though consumers may have fewer places to buy them. Regulatory Push: Senators are working on a hemp compromise, while veterans’ groups urge Congress to regulate intoxicating products rather than effectively drive them off shelves. Retail Expansion: Massachusetts regulators approved a framework for cannabis dispensary drive-throughs, with age checks and security requirements aimed at keeping service convenient and controlled.
Retail Access: Massachusetts regulators unanimously cleared cannabis dispensaries to offer drive-through service under existing security and ID-check rules, subject to commission review. Hemp Restrictions: Illinois’ new law limits hemp products sold outside dispensaries to 0.4 mg of THC per container; one Carbondale shop says 30–40% of its products came off the shelves. A separate federal restriction due Dec. 11 could also threaten hemp-derived THC products, as Kentucky Rep. James Comer calls for Congress to reverse it. Cultivation Technology: Cann Group and La Trobe researchers are using AI-powered imaging to spot stress and disease in medicinal cannabis plants before symptoms appear and help predict harvest timing. Workforce: Workers at TerrAscend’s Apothecarium in Phillipsburg, New Jersey, voted to join UFCW Local 360, beginning negotiations over wages, benefits and conditions. Hemp Standards: ASTM International is exploring a dedicated committee to develop research and standards for hemp used in food, textiles, plastics and construction.
CBD Advertising: Meta and Mike Huckabee agreed to end a lawsuit over Facebook ads falsely claiming his endorsement of CBD products; a judge dismissed the case. Hemp-THC Rules: Missouri businesses are clearing shelves and closing as new restrictions take effect. A federal law set to take effect Dec. 11 could remove many hemp-derived THC products from stores, putting more businesses and jobs at risk. Product Standards: A report found 86% of products reviewed lacked required label information, with many overstating THC content, renewing calls for stronger oversight. CBD Research: Avecho Biotechnology has resumed recruitment for the final cohort of its late-stage CBD insomnia trial. An interim review supports continuing without expanding the study; a successful result could pave the way for a registration application in Australia.
Product Compliance: New University of Colorado research found only one in seven cannabis products had all required warning labels, while more than half of flower products overstated THC potency. Hemp Rules: U.S. federal THC limits set to take effect Dec. 11 are prompting hemp businesses to clear shelves and brace for disruption; some reports warn most current products could be affected. Testing Concerns: A $470,000 machine intended to detect pesticides in legal cannabis reportedly failed badly, raising questions about testing reliability and consumer protections. Industry Research: A new federally funded Oklahoma study will investigate workplace health risks for medical cannabis workers, including exposure to dust and elevated carbon dioxide.
Hemp Rules: Milwaukee businesses warn the federal THC limit taking effect Dec. 11 could wipe out most hemp-derived products; some suppliers have already stopped production, while retailers and advocates push for alternatives and legal challenges. CBD Medicine: Morocco has launched its first locally made cannabis-based epilepsy medicine, with highly purified CBD as its active ingredient. The manufacturer plans exports after meeting domestic demand. Market Growth: Australia’s medical cannabis market is forecast to reach $2.6 billion by 2035, while South Africa’s eThekwini advances a three-year cannabis and hemp commercialisation pilot. Regulatory Shifts: Massachusetts’ Cannabis Control Commission is moving ahead with an overhaul of cannabis testing rules after industry pressure.
Hemp Rules Squeeze Businesses: New U.S. federal restrictions are already prompting hemp shops in Missouri and elsewhere to clear shelves or close, while a further THC limit due Dec. 11 threatens more products. Illinois’ restrictions are in force, though some retailers have won a delay while their lawsuit proceeds. Industry Support: eThekwini is advancing a three-year pilot to help local cannabis and hemp growers enter formal markets with training, genetics and compliance guidance. Banking Hurdle: Saint Lucia regulators and lenders are weighing how legal cannabis businesses can access banking; industry leaders warn that without it, paying staff, suppliers and taxes will be difficult. Regulatory Changes: Massachusetts regulators have advanced an overhaul of cannabis testing rules, following industry calls for updated standards.
Illinois Market Shift: New restrictions on hemp-derived THC took effect Thursday, but enforcement is paused until Nov. 19 for some retailers covered by a federal lawsuit. Licensed dispensaries expect to gain customers as smoke shops and other sellers lose products. Federal Rules: Hemp businesses face a bigger deadline on Dec. 11, when a 0.4-milligram total-THC-per-container limit could make most current hemp products illegal. Missouri shops are already clearing shelves and closing, while businesses and lawmakers seek ways to blunt the impact. Product Research: A lab study found CBG’s anti-inflammatory effects on brain immune cells were inconsistent and varied by dose, adding caution to supplement claims. Testing Standards: Massachusetts regulators are reviewing cannabis testing changes that would tighten contaminant limits, require retesting of failed products and disclose when products have been remediated.
Hemp Rules: Federal restrictions set for Dec. 11 would cap finished hemp products at 0.4 milligrams of total THC per container; industry estimates suggest roughly 95% of current hemp-derived products could be affected. Businesses are clearing shelves and weighing lawsuits, while advocates and lawmakers seek ways to preserve access. State Fallout: Illinois restrictions took effect Thursday, though enforcement is paused until Nov. 19 for some businesses in a federal lawsuit. A Peoria dispensary expects more customers as unlicensed retailers face limits; Missouri businesses have also pulled products and closed shops. Cannabis Standards: Massachusetts regulators are advancing testing rules that would require testing before sale and clearer labels for products that have been sanitized or remediated. CBD Research: Lab tests found cannabigerol’s anti-inflammatory effects on brain immune cells were inconsistent and dose-dependent; high concentrations damaged cells, underscoring that supplement claims need further study.
Federal Hemp Rules: Kentucky Rep. James Comer is seeking a path to keep hemp products legal before a Dec. 11 deadline threatens many hemp-derived THC and CBD products. Businesses warn there’s no sell-through period for remaining inventory. Retail Fallout: Missouri shops are pulling products and some businesses are closing. Illinois has delayed enforcement for some companies suing over its ban, while other retailers rush to clear shelves. Business Risks: Hemp operators also face gaps in insurance coverage as the deadline nears, adding pressure to an industry already grappling with closures and an uncertain regulatory future.
Hemp Rules: New restrictions are squeezing hemp retailers: Missouri’s law now bars many hemp-derived THC products outside licensed dispensaries, with shops clearing shelves and some closing. Federal limits are also taking effect, with further restrictions due Dec. 11. Illinois Lawsuit: Illinois has delayed enforcement for businesses challenging its 0.4-milligram THC cap until at least a Nov. 19 court hearing, offering a temporary reprieve while the wider market remains uncertain. Market Outlook: Australia’s medical cannabis market is forecast to grow from about $782 million in 2025 to $2.67 billion by 2035; hemp-based products account for a reported 54% share.
Federal Hemp Showdown: New restrictions on intoxicating hemp products are due Dec. 11, and industry advocates are pressing Congress for an alternative, warning the rules could force businesses to close. State-Level Fallout: Missouri now bars unlicensed retailers from selling intoxicating hemp products, while Illinois sellers rushed to clear THC drinks before a new ban took effect. A Tampa shop is using DoorDash to move inventory ahead of the federal deadline. Product Compliance: A Colorado study found just one in seven cannabis products carried all required warnings and details, highlighting persistent labeling gaps for consumers and regulators.
Hemp Rules Tighten: Federal restrictions on hemp-derived THC are reshaping the market, while a broader THC cap is due in December. Illinois has begun enforcing its ban, though roughly 250 businesses that sued have temporary protection; Missouri’s new rules are already pushing some hemp retailers to close. Texas Policy Shift: Democratic lawmakers have filed bills to legalize adult-use cannabis, as businesses also press for changes to the state’s hemp laws. Company Watch: MediPharm Labs reported a second consecutive profitable quarter, with revenue up 18% from Q2; Avicanna also posted positive adjusted EBITDA. Industry Consolidation: Tilray plans to close Redecan’s Fenwick cultivation site by the end of January, shifting production to Quebec and Cayuga to cut costs.
Hemp Rules: With federal restrictions on many hemp-derived THC products set to take effect Dec. 11, businesses are racing to adapt. Minnesota retailers face uncertainty over sales and distribution, while Illinois has delayed enforcement of its new hemp rules for businesses involved in a lawsuit. In Missouri, new regulations shifting many intoxicating hemp products into the regulated cannabis system are prompting some shops to close; the law does not ban all CBD products. CBD Business: UK wellness brand HempWell has secured a phased, multi-million-pound investment from fitness and recovery company JJ Double Gold. The funding is intended to expand production and support growth into areas including women’s health, mental health and sports recovery.
Federal Hemp Rules: Hemp businesses are approaching a Nov. 12 federal restriction deadline without FDA guidance Congress ordered nine months ago; broader limits are scheduled for Dec. 11, leaving growers, processors and retailers unsure which products can stay on shelves. Illinois Fallout: The state’s new THC-product limits threaten hemp beverage sales and other businesses, but enforcement is delayed for some companies that sued while a court challenge proceeds. Texas Market: Democratic lawmakers have filed bills to legalize marijuana for the 2027 session, opening a potential new market, though major political hurdles remain. Enforcement: Missouri’s attorney general sued four retailers accused of selling marijuana products as legal hemp, signaling stepped-up scrutiny of intoxicating cannabinoid sellers.
Federal Hemp Rules: Looming restrictions on hemp-derived THC are putting retailers under pressure: a Kansas CBD shop says it must close, while Texas businesses worry about inventory and jobs ahead of the Dec. 11 deadline. Illinois Court Fight: A legal challenge has temporarily delayed enforcement of the state’s hemp ban for about 250 businesses until at least Nov. 19, offering some retailers a brief reprieve. CBD Growth Abroad: MediPharm Labs launched an authorized full-spectrum CBD oral oil in Brazil, made at its Ontario facility under pharmaceutical standards. Retail Access: Portland is considering allowing cannabis retailers to use existing drive-through and walk-up windows, while Texas lawmakers have filed bills to legalize and regulate adult-use cannabis.
Illinois Hemp Rules: The state has agreed to pause enforcement of its new hemp law against businesses suing over the restrictions until Nov. 19. The law limits most hemp-derived THC products to licensed dispensaries, while allowing CBD products with less than 0.4 milligrams of THC. Federal Deadline: Minnesota and Chicago businesses are bracing for a federal limit on hemp-derived products due Dec. 11, with retailers and beverage makers warning of lost sales and potential closures. Texas Legislation: Democrats filed bills to legalize adult-use cannabis, including licensed sales and home growing, but the Republican-led Senate remains a major hurdle; the proposals exclude hemp products.
Hemp Rules: Federal restrictions set for Dec. 11 threaten many hemp-derived THC drinks, gummies and edibles, leaving retailers unsure what they can sell. The FDA is also nine months late on legally required hemp guidance. Texas Court Fight: An appeals court canceled arguments in a challenge to state hemp rules, leaving the case for newly elected Democratic justices to hear after they take office in January. Industry Moves: Vireo Growth completed its acquisition of FLUENT, while Village Farms reported record cannabis revenue. Medical Research: India’s CSIR-IIIM reviewed a cannabis research project aimed at developing medicines for pain and conditions including epilepsy and cancer.
Sign up for:
CBD Industry Today
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.